Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 33342-272

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 33342-272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

15mg-100s-carton (Cyclobenzaprine 15mg 100s Cart)

This is a description of Cyclobenzaprine Hydrochloride Extended-Release Capsules, USP 15 mg. The capsules are manufactured by Macleods Pharmaceuticals in India and distributed by Macleods Pharma USA. The packaging includes blister cards with 100 capsules in 10 unit-dose packs. The batch number, expiration date, and storage instructions are provided. The medication is not child-resistant, and it is important to keep it out of the reach of children. The usual dosage for adults is one or two capsules taken once daily at approximately the same time each day. For detailed information, refer to the accompanying package insert.*

FDA Label Image

15mg-60s (Cyclobenzaprine 15mg 60s Cont)

This text contains information about Cyclobenzaprine Hydrochloride Extended-Release Capsules, USP 15mg. It provides guidance on the usual dosage for adults, storage instructions, and safety precautions. The medication is manufactured by Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. It is important to keep the medication out of reach of children and store it in a tight, light-resistant container at the recommended temperature range.*

FDA Label Image

30mg-100s-carton (Cyclobenzaprine 30mg 100s Cart)

This text provides information about Cyclobenzaprine Hydrochloride Extended-Release Capsules, including details such as the number of capsules in a blister pack, dosage instructions for adults, manufacturing details, expiration date, and storage recommendations. It also emphasizes that blister cards are not child-resistant and advises to keep the medication out of reach of children. The medication is manufactured by Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd in India. The usual dosage is one capsule taken once daily at approximately the same time. The medication should be stored at room temperature, and in a light-resistant container.*

FDA Label Image

30mg-60s (Cyclobenzaprine 30mg 60s Cont)

This text contains information about Cyclobenzaprine Hydrochloride extended-release capsules with a dosage recommendation of 30 mg for adults. The capsules are to be taken once daily at the same time each day. The medication is stored at a temperature range of 20°C to 25°C and dispensed in a light-resistant container. The product is manufactured by Macleods Pharmaceuticals Ltd in India. The National Drug Code (NDC) for the product is 33342-273-09.*

FDA Label Image

Structure (Cyclobenzaprine Chemical Structure)

FDA Label Image

Step-4 (Cyclobenzaprine Step 4)

FDA Label Image

Step-5 (Cyclobenzaprine Step 5)

FDA Label Image

Step-6 (Cyclobenzaprine Step 6)

FDA Label Image

Step-7 (Cyclobenzaprine Step 7)

FDA Label Image

Step-8 (Cyclobenzaprine Step 8)

FDA Label Image

Step-9 (Cyclobenzaprine Step 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.